Should You Invest in Edwards Lifesciences Corp (EW) Now?

Edwards Lifesciences Corp (NYSE: EW) has a higher price-to-earnings ratio of 52.18x compared to its average ratio, The 36-month beta value for EW is at 1.12. Analysts have varying views on the stock, with 10 analysts rating it as a “buy,” 5 rating it as “overweight,” 17 as “hold,” and 1 as “sell.”

The public float for EW is 574.68M, and currently, shorts hold a 1.28% of that float. The average trading volume for EW on June 03, 2025 was 4.89M shares.

EW) stock’s latest price update

Edwards Lifesciences Corp (NYSE: EW)’s stock price has plunge by -0.15relation to previous closing price of 78.22. Nevertheless, the company has seen a 4.15% surge in its stock price over the last five trading sessions. zacks.com reported 2025-05-23 that EW’s new late-breaking clinical data shows early intervention in AS may slash significant costs and improve patient outcomes.

EW’s Market Performance

Edwards Lifesciences Corp (EW) has seen a 4.15% rise in stock performance for the week, with a 3.88% gain in the past month and a 9.40% surge in the past quarter. The volatility ratio for the week is 0.63%, and the volatility levels for the past 30 days are at 1.11% for EW. The simple moving average for the past 20 days is 2.49% for EW’s stock, with a 10.04% simple moving average for the past 200 days.

Analysts’ Opinion of EW

Many brokerage firms have already submitted their reports for EW stocks, with Piper Sandler repeating the rating for EW by listing it as a “Overweight.” The predicted price for EW in the upcoming period, according to Piper Sandler is $80 based on the research report published on April 24, 2025 of the current year 2025.

Stifel, on the other hand, stated in their research note that they expect to see EW reach a price target of $90, previously predicting the price at $75. The rating they have provided for EW stocks is “Buy” according to the report published on January 30th, 2025.

Wolfe Research gave a rating of “Underperform” to EW, setting the target price at $60 in the report published on January 16th of the current year.

EW Trading at 6.24% from the 50-Day Moving Average

After a stumble in the market that brought EW to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -18.01% of loss for the given period.

Insider Trading

Reports are indicating that there were more than several insider trading activities at EW starting from BOBO DONALD E JR, who sale 2,570 shares at the price of $77.40 back on Jun 02 ’25. After this action, BOBO DONALD E JR now owns 50,356 shares of Edwards Lifesciences Corp, valued at $198,911 using the latest closing price.

BOBO DONALD E JR, the Officer of Edwards Lifesciences Corp, proposed sale 2,570 shares at $77.40 during a trade that took place back on Jun 02 ’25, which means that BOBO DONALD E JR is holding shares at $198,911 based on the most recent closing price.

Stock Fundamentals for EW

Current profitability levels for the company are sitting at:

  • 0.27 for the present operating margin
  • 0.79 for the gross margin

The net margin for Edwards Lifesciences Corp stands at 0.75. The total capital return value is set at 0.13. Equity return is now at value 16.73, with 12.68 for asset returns.

Based on Edwards Lifesciences Corp (EW), the company’s capital structure generated 0.07 points at debt to capital in total, while cash flow to debt ratio is standing at 0.77.

Currently, EBITDA for the company is 1.72 billion with net debt to EBITDA at -1.32. When we switch over and look at the enterprise to sales, we see a ratio of 7.85. The receivables turnover for the company is 7.61for trailing twelve months and the total asset turnover is 0.42. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.45.

Conclusion

In conclusion, Edwards Lifesciences Corp (EW) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts

favicon-nh
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.